Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction - Wikidata - awgldk - TriplyDB

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

http://www.wikidata.org/entity/Q28274593

about

High-sensitivity ST2 for prediction of adverse outcomes in chronic heart failure Prognostic biomarkers in acute coronary syndrome State of the Art: Newer biomarkers in heart failure Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry Diagnostic Value of Soluble Suppression of Tumorigenicity-2 for Heart Failure.Prognostic and diagnostic value of plasma soluble suppression of tumorigenicity-2 concentrations in acute respiratory distress syndrome.Biomarkers in acute myocardial infarction.Serum Soluble ST2 and Diastolic Dysfunction in Hypertensive Patients.Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome Soluble ST2, a modulator of the inflammatory response, in preterm and term labor Daily exposure to dust alters innate immunity Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.The IL-33/ST2 pathway: therapeutic target and novel biomarker.Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact Soluble ST2 and interleukin-33 levels in coronary artery disease: relation to disease activity and adverse outcome Prognostic Impact of Early ST-Segment Resolution and Biochemical Markers in Patients With ST-Elevation Myocardial Infarction.Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community.Membrane translocation of IL-33 receptor in ventilator induced lung injury Combined biomarker analysis for risk of acute kidney injury in patients with ST-segment elevation myocardial infarction Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.Cardiovascular biomarkers in acute Kawasaki disease.Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis.Advancing cardiovascular biology and medicine via proteomics: Opportunities and present challenges of cardiovascular proteomics Soluble ST2 protein in chronic heart failure is independent of traditional factors.Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.Prognostic Value of Soluble ST2 During Hospitalization for ST-Segment Elevation Myocardial Infarction.Multimarker Risk Stratification in Patients With Acute Myocardial Infarction Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.Potential Markers in Cardiac Hypertrophy?Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling.Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection.Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation Comparison Between Soluble ST2 and High-Sensitivity Troponin I in Predicting Short-Term Mortality for Patients Presenting to the Emergency Department With Chest Pain.ST2 in emergency department patients with noncardiac dyspnea.Soluble ST2 predicts elevated SBP in the community

P2860

Q24610732-4C4C105B-882C-4B4A-AE84-DF6B36172FDD Q26738521-27444B7B-2C06-472A-9871-D539FF8D6366 Q27027899-CDE29E6A-A09D-406C-AE71-E0A6B129AA44 Q28253329-153BE217-9477-400C-8E08-EF2D88A2D4AD Q28395328-23D9779E-3562-4818-96A1-CC98DE106A39 Q30386714-FB59B007-6608-4DDA-A60A-7BDD582C2672 Q30409730-2ACC8C54-BFCD-44FF-B8A8-6937DE453238 Q33596823-D62D72D6-C378-4A73-9F20-3920B4C6D80B Q33711545-C5872923-BEB7-4423-AC18-5DDF4281A3DE Q34032238-A88E78F7-618E-42D4-9AA3-4CB7FE60F561 Q34164039-6A229B8A-9E27-4E8E-97EB-AC50ADDFF204 Q34166427-F58CA958-D592-4534-8D4F-03EBC0DB0DEA Q34300880-6778BE3F-A3E1-4DDF-A939-B7050276AAD0 Q34408467-49DB1024-3257-477C-B265-C64C4E359D19 Q34462325-946FE847-5C9A-40B2-8EA6-70E6673CD49E Q34536010-7B331333-81AE-4BAD-AE40-686A3B96075F Q34619975-FFB1B396-4F75-4889-9AA6-C70ACF60EA01 Q34776884-9BA5FD2B-515E-460C-8FCC-6B29FBC0C660 Q35112353-9537B4E9-B081-4796-BF59-18DB89900CBA Q35153947-59C586BB-509E-49B6-A3C0-05AAE7B44964 Q35154432-C396443A-457A-4495-B6B3-D0798D402F43 Q35224090-4A0AD028-CD26-4386-AF4E-27195697F65B Q35224970-75DDEA65-A676-47D1-B4CF-E26A2219A3B6 Q35326877-890C9C00-B825-4DE0-8E52-15EAADB11A32 Q35588992-CD908EBB-B40C-4DC3-B1D8-D83759D1FC2F Q35658781-21F83955-B609-4634-A0C4-E6D3770A9990 Q35782067-DD335372-12C8-4B1F-B44A-08AEAD493F44 Q36594226-350D1446-6297-4F09-85B6-DEA37645B250 Q36686088-FEB5906C-2C05-458E-ABB6-C3F5B6F875DD Q36851584-2DEBBAA6-B00A-482D-91E5-538E9A3718CA Q36864318-846A4A6C-9599-40E2-9124-0FC51EF58ACD Q36956650-654CF004-EECE-4D03-97E3-25CAD060FCB7 Q37087572-F72A2861-2996-47AE-9DE2-BA60F2318F32 Q37155198-BEC04DB5-2339-4256-9A38-712DAD670D64 Q37200836-82F832E3-F024-4782-BBC5-310DD16906D0 Q37363858-C7B772BD-7CC5-4256-BEE6-C393CD66DD28 Q37449938-95AB4592-AE0E-499A-ACBD-94A38B672D96 Q37547780-30DE3AE2-2DB5-46D0-B6F3-528515E9040E Q37680118-5DB6394C-EBF4-441D-9255-4A63D2570FFE Q37702150-8361B985-EC9E-48FF-9C9E-8E679021B2AD

P2860

Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction

http://www.wikidata.org/entity/Q28274593

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Complementary roles for biomar ...... levation myocardial infarction

@ast

Complementary roles for biomar ...... levation myocardial infarction

@en

Complementary roles for biomar ...... levation myocardial infarction

@nl

type

label

Complementary roles for biomar ...... levation myocardial infarction

@ast

Complementary roles for biomar ...... levation myocardial infarction

@en

Complementary roles for biomar ...... levation myocardial infarction

@nl

prefLabel

Complementary roles for biomar ...... levation myocardial infarction

@ast

Complementary roles for biomar ...... levation myocardial infarction

@en

Complementary roles for biomar ...... levation myocardial infarction

@nl

P1433

Q28274593-1C2BD4DA-4AF5-402B-A851-49434C80DC71

P1476

Q28274593-36F7264F-10BC-4D6C-A237-44484C06E639

P2093

Q28274593-0233C87E-3822-4D86-9B1B-7D455FB865E9

Q28274593-33C8542D-19A2-4B53-A06E-D8DC1FC196A0

Q28274593-79348614-459B-4DCB-805D-5C34B199A69F

Q28274593-8045C784-E796-4D5E-BD8A-F1C5EB90B781

Q28274593-8BE4D3C6-E21E-4B85-BAEC-2EB69B493977

Q28274593-A6DBBD5A-18FA-4813-843D-51AAAE93DE99

Q28274593-B75C0A01-B597-4E20-BAFC-65094F031486

Q28274593-B8B1A8CF-AA3D-420D-8544-66E87FFEB0F4

Q28274593-C432632E-4934-40BA-9334-FFA1D82DB7CE

Q28274593-D936F3BD-B6A8-461D-B7C9-DD73C94D45A1

P2860

Q28274593-04CA7DB8-6390-477C-BE5A-C76559F0F8F7

Q28274593-0DE20ABB-CD19-4583-8C0A-1B1650151AA1

Q28274593-3E80CF7B-81B7-4515-9394-D862DC8DE466

Q28274593-506E5B18-7B70-4006-AFF9-9816C5CE1D91

Q28274593-5BD236B5-A03D-41B3-AE8B-12E4D8328BAE

Q28274593-5E8D7939-BD4A-40CB-AA83-0232153420ED

Q28274593-60459231-D762-4952-B57A-1D6BF536B855

Q28274593-679677C1-4E4E-42F0-8716-7DE39DF5200A

Q28274593-80CC115E-41DE-44CE-8987-6781451600C4

Q28274593-82E42701-09DC-444D-8B64-24220248BC05

P304

Q28274593-29A1261E-4874-4854-81E2-5198070A90B0

P31

Q28274593-899ED076-BCFE-40A5-90CE-D996A5D9E064

P3181

Q28274593-7D4BE134-8CBD-4973-B5FF-08F2CCADFAC7

P356

Q28274593-A5F809DD-E8D9-412D-A38A-44778E0EB67C

P407

Q28274593-CD7B0096-09B4-4F82-8C4A-2918E03AFD4B

P433

Q28274593-AFF2BF7A-995B-4238-BE0B-B9712931DAB4

P478

Q28274593-699EFA49-9184-49F7-BBD6-ED9C3C48322D

P577

Q28274593-B9179B04-BD28-4FB2-8079-D1A767A61A1F

P698

Q28274593-F920F725-0FA9-48FA-9ED5-E60C8F4D1D8B

P921

Q28274593-058B7CBD-C44D-47C1-BFF1-3105D330BDC9

Q28274593-5A0CC92F-D1EA-4AD0-BE27-0A2AE0A909C9

Q28274593-5A29FCE2-97A2-4D6D-8A97-3C3E52BEAC05

Q28274593-B86BEFAE-AAB1-4B20-BE2D-2C488AA366FC

P932

Q28274593-47EC2824-FAF9-446D-AC17-C55E857DB8F9

P3181

P356

CIRCULATIONAHA.107.728022

P1433

P1476

Complementary roles for biomar ...... levation myocardial infarction

@en

P2093

Catherine MacGillivray

http://www.w3.org/2001/XMLSchema#string

Christophe Bode

http://www.w3.org/2001/XMLSchema#string

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

David A Morrow

http://www.w3.org/2001/XMLSchema#string

Luke J Higgins

http://www.w3.org/2001/XMLSchema#string

Marc S Sabatine

http://www.w3.org/2001/XMLSchema#string

Nader Rifai

http://www.w3.org/2001/XMLSchema#string

Richard T Lee

http://www.w3.org/2001/XMLSchema#string

Robert E Gerszten

http://www.w3.org/2001/XMLSchema#string

Wei Guo

http://www.w3.org/2001/XMLSchema#string

P2860

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs.

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction.

The prognostic value of serum troponin T in unstable angina.

P304

1936-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

330421

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/CIRCULATIONAHA.107.728022

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

117

http://www.w3.org/2001/XMLSchema#string

P577

2008-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18378613

http://www.w3.org/2001/XMLSchema#string

P921

P932

4273564

http://www.w3.org/2001/XMLSchema#string